Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

4 Stocks Breaking Good: CGC, GEMP, HTGM, XNCR

Published 06/05/2018, 12:19 AM
Updated 07/09/2023, 06:31 AM

Canopy Growth Corp (NYSE:CGC), recently listed on the NYSE after the huge run-up, having gone from 5.00 to 35, and change, a 7-fold increase. It then came down, based out, broke out, pulled back, and it’s moving again, jumping 1.53, or 5.25%, to 30.65, on a solid 2.8 million shares on Monday. It was one of the biggest volume days since January. Anything above 31.31, and I think it is headed for a retest of near 36. Eventually, I think we are going to see this stock make a bigger move. Midchannel comes in at 40-42. That will be my secondary target. So targets are 35-6 and 40-2.

Gemphire Therapeutics Inc (NASDAQ:GEMP) had another good follow-through day on Monday, making it the third day in a row now, going from the 5.85 range to Monday's high of 7.46. It was up 40 cents, or 6%, to 7.12, on 266,854 shares traded. There’s a little bit of resistance in the 7.82 zone, but if it gets through that and tests the higher-high around 8 1/4, then it’s on its way to 10-11.

HTG Molecular Diagnostics Inc (NASDAQ:HTGM) made an important move on Monday, popping 22 cents, or 5.63%, to 4.13, on a million shares. That was bigger volume but not great. Still, that could be the beginning of a bigger move. It was up seven days in a row, taking out the May high at 4.40, and then about 4.80. Once it gets through that zone, if it does, targets are 5.15, and then 5.75-.80. Those are the levels to watch out for resistance going forward.

Xencor Inc (NASDAQ:XNCR), a swing trade of ours, is working out nicely. It broke out of a base, ran up sharply, consolidated for a month, popped out of a wedge, and has been running up ver since. On Monday, it gained another 1.09, or 2.64%, to 42.36, on 367,239 shares traded. Targets are 46-7, and beyond that 54-5.

Stocks on the long side included Canopy Growth Corporation (CGC), Ceragon Networks Ltd (NASDAQ:CRNT), Cronos Group Inc. (CRON), CohBar, Inc. (CWBR), Fossil Group Inc (NASDAQ:FOSL), Gemphire Therapeutics Inc. (GEMP), Genomic Health, Inc. (GHDX), Heron Therapeutics, Inc. (HRTX), HTG Molecular Diagnostics, Inc. (HTGM), Immunomedics, Inc. (IMMU), Macy's, Inc. (NYSE:M), Nuvectra Corporation (NVTR), Rocket Pharmaceuticals Inc (NASDAQ:RCKT), Resonant Inc. (RESN), Sogou Inc. (SOGO), Square, Inc. (NYSE:SQ), Tandem Diabetes Care, Inc. (TNDM), Twitter Inc (NYSE:TWTR), Vicor Corporation (VICR), and Xencor, Inc. (XNCR).

Watch video here.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.